4
Changes in Ownership
RxSight, Inc. Filed Acc 0000950170-24-008423
Chief Financial Officer sold 31,772 shares at $47.11 ($1,496,706)
- Chief Financial Officer acquired 36,272 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Thunen Shelley B Chief Financial Officer | 2024-01-26 | Option exercise | +4,500 | $4.34 | $19,530 | 6,791 | D |
| Thunen Shelley B Chief Financial Officer | 2024-01-26 | Option exercise | +31,772 | $15.08 | $479,122 | 38,563 | D |
| Thunen Shelley B Chief Financial Officer | 2024-01-26 | Sale | −31,772 | $47.11 | $1,496,706 | 6,791 | D |
| Derivatives | |||||||
| Thunen Shelley B Chief Financial Officer | 2024-01-26 | Option exercise · Stock Option (right to buy) | −4,500 | 24,540 | D | ||
| Thunen Shelley B Chief Financial Officer | 2024-01-26 | Option exercise · Stock Option (right to buy) | −31,772 | 16,629 | D | ||
| Open-market sales · 31,772 sh · avg $47.11 · $1,496,706 | |||||||
Loading xslF345X05/ownership.xml…